Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation

Saowanee Ngamruengphong, Kristina M. Seeger, Luke M. McCrone, Maria Moris, Stephen J. Garrison, Surakit Pungpapong, Andrew P. Keaveny, Massimo Raimondo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Solid organ transplant recipients have an increased risk of cancer due to immunosuppressive therapy. Pancreatic cystic lesions are increasingly being detected, some with malignant potential. We aimed to determine the prevalence of these lesions and describe their clinical course in these patients. Methods: We identified the presence of pancreatic cystic lesions in a retrospective cohort of 3188 consecutive solid organ transplant recipients from 2000 to 2013 and compared lesion characteristics at initial and follow-up imaging, when available. Results: Lesion prevalence was 11.4% (365/3188), and increased with age. Median diameter of the largest lesions was 7. mm (range: 1-31. mm). We noted worrisome features in two patients (0.54%) at the time of cyst diagnosis. Of 155 patients who underwent follow-up imaging, the cysts size remained stable in 80%, increased in 16%, and decreased in 4%. Two patients (1.3%) developed features concerning for cancer. One underwent pancreatic surgery, and pathology confirmed the presence of high-grade dysplasia. The other continued with conservative management due to multiple comorbidities. Conclusions: Pancreatic cystic lesions are common in solid organ transplant recipients. In lesions without high-risk features, the development of features worrisome for cancer is rare. These lesions can be managed conservatively, and their presence should not affect transplant eligibility.

Original languageEnglish (US)
Pages (from-to)417-422
Number of pages6
JournalDigestive and Liver Disease
Volume47
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Organ Transplantation
Pancreas
Transplants
Cysts
Neoplasms
Immunosuppressive Agents
Comorbidity
Pathology
Transplant Recipients
Therapeutics

Keywords

  • Immunosuppressive therapy
  • Organ transplantation
  • Pancreatic cystic neoplasms

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation. / Ngamruengphong, Saowanee; Seeger, Kristina M.; McCrone, Luke M.; Moris, Maria; Garrison, Stephen J.; Pungpapong, Surakit; Keaveny, Andrew P.; Raimondo, Massimo.

In: Digestive and Liver Disease, Vol. 47, No. 5, 01.05.2015, p. 417-422.

Research output: Contribution to journalArticle

Ngamruengphong, Saowanee ; Seeger, Kristina M. ; McCrone, Luke M. ; Moris, Maria ; Garrison, Stephen J. ; Pungpapong, Surakit ; Keaveny, Andrew P. ; Raimondo, Massimo. / Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation. In: Digestive and Liver Disease. 2015 ; Vol. 47, No. 5. pp. 417-422.
@article{f1ea683c7b26403a9f96a46e7ff1521f,
title = "Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation",
abstract = "Background: Solid organ transplant recipients have an increased risk of cancer due to immunosuppressive therapy. Pancreatic cystic lesions are increasingly being detected, some with malignant potential. We aimed to determine the prevalence of these lesions and describe their clinical course in these patients. Methods: We identified the presence of pancreatic cystic lesions in a retrospective cohort of 3188 consecutive solid organ transplant recipients from 2000 to 2013 and compared lesion characteristics at initial and follow-up imaging, when available. Results: Lesion prevalence was 11.4{\%} (365/3188), and increased with age. Median diameter of the largest lesions was 7. mm (range: 1-31. mm). We noted worrisome features in two patients (0.54{\%}) at the time of cyst diagnosis. Of 155 patients who underwent follow-up imaging, the cysts size remained stable in 80{\%}, increased in 16{\%}, and decreased in 4{\%}. Two patients (1.3{\%}) developed features concerning for cancer. One underwent pancreatic surgery, and pathology confirmed the presence of high-grade dysplasia. The other continued with conservative management due to multiple comorbidities. Conclusions: Pancreatic cystic lesions are common in solid organ transplant recipients. In lesions without high-risk features, the development of features worrisome for cancer is rare. These lesions can be managed conservatively, and their presence should not affect transplant eligibility.",
keywords = "Immunosuppressive therapy, Organ transplantation, Pancreatic cystic neoplasms",
author = "Saowanee Ngamruengphong and Seeger, {Kristina M.} and McCrone, {Luke M.} and Maria Moris and Garrison, {Stephen J.} and Surakit Pungpapong and Keaveny, {Andrew P.} and Massimo Raimondo",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.dld.2015.02.011",
language = "English (US)",
volume = "47",
pages = "417--422",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation

AU - Ngamruengphong, Saowanee

AU - Seeger, Kristina M.

AU - McCrone, Luke M.

AU - Moris, Maria

AU - Garrison, Stephen J.

AU - Pungpapong, Surakit

AU - Keaveny, Andrew P.

AU - Raimondo, Massimo

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Background: Solid organ transplant recipients have an increased risk of cancer due to immunosuppressive therapy. Pancreatic cystic lesions are increasingly being detected, some with malignant potential. We aimed to determine the prevalence of these lesions and describe their clinical course in these patients. Methods: We identified the presence of pancreatic cystic lesions in a retrospective cohort of 3188 consecutive solid organ transplant recipients from 2000 to 2013 and compared lesion characteristics at initial and follow-up imaging, when available. Results: Lesion prevalence was 11.4% (365/3188), and increased with age. Median diameter of the largest lesions was 7. mm (range: 1-31. mm). We noted worrisome features in two patients (0.54%) at the time of cyst diagnosis. Of 155 patients who underwent follow-up imaging, the cysts size remained stable in 80%, increased in 16%, and decreased in 4%. Two patients (1.3%) developed features concerning for cancer. One underwent pancreatic surgery, and pathology confirmed the presence of high-grade dysplasia. The other continued with conservative management due to multiple comorbidities. Conclusions: Pancreatic cystic lesions are common in solid organ transplant recipients. In lesions without high-risk features, the development of features worrisome for cancer is rare. These lesions can be managed conservatively, and their presence should not affect transplant eligibility.

AB - Background: Solid organ transplant recipients have an increased risk of cancer due to immunosuppressive therapy. Pancreatic cystic lesions are increasingly being detected, some with malignant potential. We aimed to determine the prevalence of these lesions and describe their clinical course in these patients. Methods: We identified the presence of pancreatic cystic lesions in a retrospective cohort of 3188 consecutive solid organ transplant recipients from 2000 to 2013 and compared lesion characteristics at initial and follow-up imaging, when available. Results: Lesion prevalence was 11.4% (365/3188), and increased with age. Median diameter of the largest lesions was 7. mm (range: 1-31. mm). We noted worrisome features in two patients (0.54%) at the time of cyst diagnosis. Of 155 patients who underwent follow-up imaging, the cysts size remained stable in 80%, increased in 16%, and decreased in 4%. Two patients (1.3%) developed features concerning for cancer. One underwent pancreatic surgery, and pathology confirmed the presence of high-grade dysplasia. The other continued with conservative management due to multiple comorbidities. Conclusions: Pancreatic cystic lesions are common in solid organ transplant recipients. In lesions without high-risk features, the development of features worrisome for cancer is rare. These lesions can be managed conservatively, and their presence should not affect transplant eligibility.

KW - Immunosuppressive therapy

KW - Organ transplantation

KW - Pancreatic cystic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=84928824326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928824326&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2015.02.011

DO - 10.1016/j.dld.2015.02.011

M3 - Article

C2 - 25804443

AN - SCOPUS:84928824326

VL - 47

SP - 417

EP - 422

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 5

ER -